Fahad Alshahrani

940 total citations
29 papers, 649 citations indexed

About

Fahad Alshahrani is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Fahad Alshahrani has authored 29 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Physiology. Recurrent topics in Fahad Alshahrani's work include Bone health and osteoporosis research (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Vitamin D Research Studies (5 papers). Fahad Alshahrani is often cited by papers focused on Bone health and osteoporosis research (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Vitamin D Research Studies (5 papers). Fahad Alshahrani collaborates with scholars based in Saudi Arabia, United Kingdom and United States. Fahad Alshahrani's co-authors include Naji Aljohani, Mussa Almalki, Yousef Al‐Saleh, Abdullah M. Alzahrani, Nasser M. Al‐Daghri, Shaun Sabico, Riad A. Sulimani, Mona A. Fouda, Abdulrahman Almaghamsi and Saad Alzahrani and has published in prestigious journals such as PLoS ONE, Nutrients and Frontiers in Endocrinology.

In The Last Decade

Fahad Alshahrani

27 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fahad Alshahrani Saudi Arabia 14 297 145 136 133 105 29 649
Marlene Pandis Austria 13 387 1.3× 160 1.1× 150 1.1× 120 0.9× 86 0.8× 33 639
Gabriela Luporini Saraiva Brazil 13 231 0.8× 124 0.9× 101 0.7× 148 1.1× 82 0.8× 21 571
Mário Rui Mascarenhas Portugal 9 428 1.4× 146 1.0× 176 1.3× 128 1.0× 56 0.5× 28 785
Ratnesh Kanwar India 18 364 1.2× 348 2.4× 165 1.2× 149 1.1× 100 1.0× 31 933
Mirjam M Oosterwerff Netherlands 11 317 1.1× 148 1.0× 99 0.7× 75 0.6× 26 0.2× 13 544
A Wallace United Kingdom 11 395 1.3× 145 1.0× 177 1.3× 102 0.8× 75 0.7× 18 637
Reda Bassali United States 9 202 0.7× 112 0.8× 123 0.9× 98 0.7× 46 0.4× 14 682
Chengchen Zhang United States 12 148 0.5× 68 0.5× 56 0.4× 113 0.8× 173 1.6× 22 541
Lauren M. Beckman United States 9 328 1.1× 89 0.6× 131 1.0× 78 0.6× 272 2.6× 13 723
Inez Schoenmakers United Kingdom 13 582 2.0× 57 0.4× 212 1.6× 210 1.6× 47 0.4× 27 783

Countries citing papers authored by Fahad Alshahrani

Since Specialization
Citations

This map shows the geographic impact of Fahad Alshahrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahad Alshahrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahad Alshahrani more than expected).

Fields of papers citing papers by Fahad Alshahrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahad Alshahrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahad Alshahrani. The network helps show where Fahad Alshahrani may publish in the future.

Co-authorship network of co-authors of Fahad Alshahrani

This figure shows the co-authorship network connecting the top 25 collaborators of Fahad Alshahrani. A scholar is included among the top collaborators of Fahad Alshahrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahad Alshahrani. Fahad Alshahrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almalki, Mussa, Faisal Aziz, Fahad Alshahrani, et al.. (2024). Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study. Pituitary. 27(2). 197–203. 10 indexed citations
2.
Mushtaq, Saima, et al.. (2023). Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients. PLoS ONE. 18(9). e0291332–e0291332. 6 indexed citations
3.
Alshahrani, Fahad, et al.. (2023). Assessment of calcium intake and recognition of calcium-rich food sources among the Saudi population. Archives of Osteoporosis. 18(1). 130–130. 1 indexed citations
4.
Al‐Saleh, Yousef, Riad A. Sulimani, Shaun Sabico, et al.. (2023). Diagnosis and management of osteoporosis in Saudi Arabia: 2023 key updates from the Saudi Osteoporosis Society. Archives of Osteoporosis. 18(1). 75–75. 13 indexed citations
5.
6.
Almalki, Mussa, et al.. (2020). Clinical Features, Therapeutic Trends, and Outcome of Giant Prolactinomas: A Single-Center Experience Over a 12-Year Period. Clinical Medicine Insights Endocrinology and Diabetes. 13. 2455242570–2455242570. 12 indexed citations
7.
Alshahrani, Fahad, John Marriott, & Anthony Cox. (2020). A qualitative study of prescribing errors among multi-professional prescribers within an e-prescribing system. International Journal of Clinical Pharmacy. 43(4). 884–892. 10 indexed citations
8.
Alshahrani, Fahad, et al.. (2018). Management of acromegaly: an exploratory survey of physicians from the Middle East and North Africa. HORMONES. 17(3). 373–381. 6 indexed citations
9.
Alshahrani, Fahad, et al.. (2018). Public knowledge and awareness about Parkinson's disease in Saudi Arabia. Journal of Family Medicine and Primary Care. 7(6). 1216–1216. 15 indexed citations
10.
Almalki, Mussa, et al.. (2017). Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review. HORMONES. 16(2). 139–149. 26 indexed citations
11.
AlHadi, Ahmad N., et al.. (2017). Knowledge of and attitudes towards electroconvulsive therapy (ECT) among psychiatrists and family physicians in Saudi Arabia. Annals of General Psychiatry. 16(1). 16–16. 18 indexed citations
12.
Almalki, Mussa, et al.. (2016). Clinical and Biochemical Characteristics of Diabetes Ketoacidosis in a Tertiary Hospital in Riyadh. Clinical Medicine Insights Endocrinology and Diabetes. 9. CMED.S39639–CMED.S39639. 12 indexed citations
13.
14.
Almalki, Mussa & Fahad Alshahrani. (2016). Options for Controlling Type 2 Diabetes during Ramadan. Frontiers in Endocrinology. 7. 32–32. 24 indexed citations
15.
Al‐Saleh, Yousef, Riad A. Sulimani, Shaun Sabico, et al.. (2015). 2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society. Annals of Saudi Medicine. 35(1). 1–12. 46 indexed citations
16.
Almalki, Mussa, et al.. (2015). Managing Prolactinomas during Pregnancy. Frontiers in Endocrinology. 6. 85–85. 21 indexed citations
17.
Almalki, Mussa, et al.. (2014). Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases. Pituitary. 18(3). 405–409. 12 indexed citations
18.
Almansour, Mohammed, et al.. (2014). A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus.. PubMed. 7(12). 5421–8. 24 indexed citations
19.
Alshahrani, Fahad & Naji Aljohani. (2013). Vitamin D: Deficiency, Sufficiency and Toxicity. Nutrients. 5(9). 3605–3616. 207 indexed citations
20.
Alshahrani, Fahad & David L. Kendler. (2012). Femoral Fractures in Osteoporotic Patients on Bisphosphnates. A Case Report. Journal of Clinical Densitometry. 15(3). 380–384. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marlene Pandis Breakdown of academic impact, for papers by Gabriela Luporini Saraiva Breakdown of academic impact, for papers by Mário Rui Mascarenhas Breakdown of academic impact, for papers by Ratnesh Kanwar Breakdown of academic impact, for papers by Mirjam M Oosterwerff Breakdown of academic impact, for papers by A Wallace Breakdown of academic impact, for papers by Reda Bassali Breakdown of academic impact, for papers by Chengchen Zhang Breakdown of academic impact, for papers by Lauren M. Beckman Breakdown of academic impact, for papers by Inez Schoenmakers
Rankless by CCL
2026